Stay updated on Pembrolizumab & Enobosarm in AR+ Metastatic TNBC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Enobosarm in AR+ Metastatic TNBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Enobosarm in AR+ Metastatic TNBC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The NIH website transition banner about updated terminology and related FAQs is no longer displayed.
    Difference
    1%
    Check dated 2026-11-08T15:13:20.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T16:22:17.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    A banner announces an NIH-wide transition from using “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T15:28:55.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T22:13:34.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The site footer revision identifier changed from v3.7.0 to v3.7.1. The study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T22:01:42.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden state with a minimal header and Home button, and a large portion of the previous study-content sections has been removed, resulting in an error-page display rather than the full study details.
    Difference
    19%
    Check dated 2026-09-20T22:12:42.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Enobosarm in AR+ Metastatic TNBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Enobosarm in AR+ Metastatic TNBC Clinical Trial page.